Therapeutic Glaucoma

>

Latest News

First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111
First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111

August 26th 2025

The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma.

Nicox releases topline data from phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension patients
Nicox releases topline data from phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension patients

August 21st 2025

PolyActiva enrolls first patient in phase 2b clinical trial of PA5108 ocular implant
PolyActiva enrolls first patient in phase 2b clinical trial of PA5108 ocular implant

August 12th 2025

Kowa initiates phase 3 safety trial of NCX 470 in Japan
Kowa initiates phase 3 safety trial of NCX 470 in Japan

August 6th 2025

First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco
First US patient receives Eyetronic glaucoma treatment at Glaucoma Center of San Francisco

July 23rd 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.